






3.1 Source and Authentication of Plant Materials 
The plant materials were collected from various locations in Malaysia and were 
identified by Dr. K. M. Wong (Formerly Institute of Science Biology, University of 
Malaya, and Forest Research Centre, Sabah) and L. E. Teo (Herbarium, Chemistry 
Department, University of Malaya). All plant materials were screened for their 
alkaloidal constituents before any chemical analysis was carried out. Voucher 
specimens are deposited at Forest Research Centre (FRC), Sepilok, Sandakan and the 
Herbarium, Chemistry Department, University of Malaya (UM).  
 
Table 3.1 : Source and authentication of plant materials 
Herbarium 
Specimen No. 
Locality Species Date of 
Collection 
Herbarium 
SAN 138327 Sabah K. pauciflora Feb 1994 FRC (Sandakan) 
KL 3632  K. grandifolia Feb 1990  











Melting points were determined with a Mel-Temp melting point apparatus and were 
uncorrected. Optical rotations were determined on a Jasco P-1020 automatic digital 
polarimeter. UV spectra were obtained on a Shimadzu UV-3101 PC spectrophotometer 
in absolute ethanol. IR spectra were recorded on a Perkin-Elmer 1600 series FT-IR or a 




C NMR spectra data were 
recorded in CDCl3 using tetramethylsilane (TMS) as internal standard on a JEOL JNM-
LA 400 and JNM-ECA 400 spectrometers at 400 and 100 MHz, respectively. Coupling 
constants (J) are reported in Hz and  in ppm. X-ray diffraction analysis was carried out 
on a Bruker SMART APEX II CCD area detector system equipped with a graphite 
monochromator and a Mo K fine-focus sealed tube (= 0.71073 Å), at 100K. The 
structure was solved by direct methods (SHELXS-97) and refined with full-matrix least-
squares on F
2
 (SHELXL-97).  ESIMS and HRESIMS were obtained using Agilent 6530 
Q-TOF mass spectrometer. HREIMS was obtained at Organic Mass Spectrometry, 
Central Science Laboratory, University of Tasmania, Tasmania, Australia. All solvents 
were distilled prior to use with the exception of diethyl ether, which was passed through 
activated neutral alumina before use. 
 
3.3 Chromatographic Methods 
 
3.3.1 Column Chromatography 
Flash chromatography was performed using Merck silica gel 9385 (230-400 Mesh 
ASTM). The ratio of silica gel to the sample was approximately 30:1 for crude samples 
and 100:1 for semi-pure fractions. The gel was made into slurry with chloroform before 
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it was packed onto the column and was allowed to equilibrate for at least an hour before 
use. The solvent systems normally used to elute the column were chloroform with 
increasing methanol gradient or diethyl ether with increasing ethyl acetate gradient. 
When diethyl ether-hexanes was used as an eluting solvent, the column was packed by 
the dry packing method. Fractions were monitored by thin layer chromatography (TLC) 
and appropriate fractions were combined and where necessary subjected to further 
separation by re-chromatography or centrifugal preparative TLC. 
 
3.3.2 Thin Layer Chromatography (TLC) 
Thin layer chromatography (TLC) was routinely used to detect and separate the various 
alkaloids. It was also used extensively for testing and selecting the right solvent systems 
for separating the alkaloids. The crude alkaloidal extracts, fractions from 
chromatography, and isolated pure alkaloids, were examined by TLC using pre-coated 5 
× 10 cm aluminium plates, 0.25 mm thickness, silica gel 60 F254 (Merck, Darmstadt, G. 
F.R). The TLC plates were spotted with a piece of fine glass capillary tube and then 
developed in saturated chromatographic tanks with various solvent systems at room 
temperature. The alkaloidal spots of the developed TLC plates were visualized under 
UV light (254 nm), followed by spraying reagents, which formed orange spots. The hRf 
values of the alkaloids are tabulated in Table 3.2. 
 
Table 3.2 : The hRf values of alkaloids isolated from Kopsia pauciflora and Kopsia  
grandifolia 
Alkaloids Solvent Systems 
 a b c d e f 
Compound 1 51 20 38 69 79 31 
Compound 2 38 11 40 63 78 14 
Compound 3 4 0 6 28 65 8 
Compound 4 19 3 17 42 69 4 
Compound 5 54 26 44 62 75 37 
 157 
 
Table 3.2, continued 
Alkaloids Solvent Systems 
a b c d e f 
Compound 6 29 5 22 40 65 4 
Compound 7 35 7 33 58 75 8 
Compound 8 58 41 55 73 77 68 
Compound 9 29 14 23 56 70 18 
Compound 10 17 5 10 18 51 9 
Compound 11 10 4 5 19 42 8 
Compound 12 10 5 8 22 45 8 
Tetrahydroalstonine (13) 84 66 78 69 90 88 
Leuconoxine (14) 34 10 36 60 77 15 
N(1)-Carbomethoxy-5,22-dioxokopsane (15) 41 11 38 50 74 17 
Kopsanone (16) 43 23 32 58 73 43 
Kopsifine (17) 36 9 34 47 63 10 
Decarbomethoxykopsifine (18) 28 5 16 27 41 6 
Paucidactine B (19) 39 4 30 43 61 17 
Kopsamine (20) 53 24 41 67 75 48 
Kopsamine N-oxide (21) 0 0 0 6 31 0 
Kopsinine (22) 35 12 18 38 52 45 
N(1)-Methoxycarbonyl-12-methoxy-16,17-kopsinine (23) 25 6 12 42 65 20 
N(1)-Methoxycarbonyl-12-hydroxy-16,17-kopsinine (24) 29 13 22 60 73 25 
Kopsinine N-oxide (25) 0 0 0 5 24 0 
N(1)-Methoxycarbonyl-11,12-dimethoxykopsinaline (26) 46 12 24 50 70 41 
Kopsilongine (27) 45 18 20 46 73 49 
Pleiocarpine (28) 47 23 36 60 70 44 
12-Methoxypleiocarpine (29) 33 9 17 38 65 26 
Pleiocarpine N-oxide (30) 0 0 0 7 26 0 
(+)-Eburnamenine (31) 30 24 25 53 68 40 
(+)-Eburnamonine (32) 37 19 19 66 82 33 
()-Eburnamine (33) 39 11 11 24 39 34 
(+)-Isoeburnamine (34) 26 9 22 33 51 21 
(+)-19-oxoeburnamine (35) 30 11 10 22 40 21 
()-19(R)-Hydroxyisoeburnamine (36) 5 0 0 11 36 0 
(+)-19(R)-Hydroxyeburnamine (37) 5 0 0 8 37 0 
(-Norpleiomutine (38) 10 0 3 24 44 7 
(-Demethylnorpleiomutine (39) 0 0 0 3 4 0 
(+)-Kopsoffinol (40) 3 0 3 16 40 0 
Grandilodine A (41) 24 10 14 32 57 21 
Grandilodine B (42) 29 5 22 56 68 9 
Grandilodine C (43) 17 4 19 53 71 3 
Lapidilectine A (44) 37 16 25 58 75 38 
Isolapidilectine A (45) 24 12 17 43 58 25 
Lapidilectam (46) 26 8 25 58 65 8 
Lapidilectine B (47) 50 25 48 74 77 42 
 
a. Ethyl acetate: Diethyl ether (1:1)                             d. Methanol: Chloroform (1:25) 
b. Ethyl acetate: Hexanes (1:1)                                    e. Methanol: Chloroform (1:10) 
c. Ethyl acetate: Chloroform (1:1)                               f. Diethyl ether 
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3.3.3 Centrifugal Preparative TLC 
Centrifugal preparative TLC was carried out using a round chromatographic plate 
measuring 24 cm in diameter with the action of a centrifugal force to accelerate mobile 
phase flow across the circular plate. To prepare the chromatographic plate, the edge of 
the plate was secured with cellophane tape to form a mould. Silica gel (Merck 7749, 
50g) was added to about 110 ml of cold distilled water. This slurry was shaken and was 
then quickly poured onto the circular glass plate before setting commenced. The circular 
glass plate was rotated while the gel was being poured to obtain an even setting. The 
plate was then left to air-dry for about an hour before being dried in an oven at 80ºC for 
about 12 hours. The sample was dissolved in a minimum volume of a suitable solvent 
and loaded at the centre of the plate while the plate was spinning to form a thin band. 
Elution was then carried with the appropriate solvent system. The fractions were 
collected, concentrated by rotary evaporation, examined by TLC and combined where 
appropriate. 
 
3.4 Spray Reagent (Dragendorff’s Reagent) 
Solution A:  0.85 g of bismuth nitrate was dissolved in a mixture of 10 ml glacial  
acetic acid and 40 ml of distilled water. 
Solution B:     8 g of potassium iodide was dissolved in 20 ml of distilled waer. 
A stock solution was prepared by mixing equal volumes of solutions A and B.  
Dragendorff’s reagent was made by mixing 1ml of stock solution with 2 ml of glacial 
acetic acid and 10 ml of distilled water. Orange spots on the developed TLC plates 
indicate the presence of alkaloids. 
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3.5 Extraction of Alkaloids 
The plant materials were dried and ground before extracting with 95% ethanol for 2-3 
days at room temperature. The ethanol extract was filtered and the residue was then re-
extracted with a fresh portion of distilled ethanol. This procedure was repeated 5 or 6 
times. The combined extract was then concentrated by distillation under reduced 
pressure using a rotary-evaporator to about a tenth of the original volume. The 
concentrated extract was then added slowly into 5% hydrochloric acid with constant 
stirring. The acidic solution was then filtered through Kieselguhr to remove the non-
alkaloidal substances. The filtrate was then basified with concentrated ammonia 
solution to about pH 10 with cooling and the liberated alkaloids were extracted 
exhaustively with chloroform. The chloroform extract was then washed with distilled 
water and dried over anhydrous sodium sulfate. Finally, the solvent was removed by 
evaporation under reduced pressure to furnish the crude alkaloidal mixture. 
 
3.6 Isolation of Alkaloids  
3.6.1 General Procedure 
The basic crude mixture obtained from the extraction procedure described above was 
initially fractionated by vacuum chromatography over silica gel. The column was eluted 
with chloroform, followed by a stepwise increase of methanol gradient. Based on TLC, 
the many fractions collected were pooled into several major fractions, which were then 
subjected to further fractionation by flash chromatography, vacuum chromatography, or 




3.6.2 Isolation of Alkaloids from Kopsia pauciflora 
Extraction of 8.5 kg of the stem-bark of K. pauciflora yielded ca. 27.7 g of crude 
alkaloidal mixture. This mixture was then subjected to repeated fractionation by various 
chromatographic methods. 40 alkaloids were obtained from this crude mixture as 
summarized in the flow diagram shown in Figure 3.1.  
 
3.6.3 Isolation of Alkaloids from Kopsia grandifolia 
Extraction of 9.0 kg of the stem-bark of K. grandifolia gave ca. 25.5 g of crude 
alkaloidal mixture. Six alkaloids were obtained from this crude mixture as summarized 
in the flow diagram shown in Figure 3.2. The leaves of the same plant gave ca. 2.5 g of 
crude material from the extraction of 0.5 kg of plant material. From this mixture, two 
alkaloids were isolated. The flow diagram depicting the isolation of the alkaloids from 
the leaves of K. grandifolia is shown in Figure 3.3.  
 












Figure 3.2 : Isolation of alkaloids from the stem-bark extract of Kopsia grandifolia 
 
 





3.7 Compound Data  
Alkaloids from K. pauciflora 
 
Compound 1 : Light yellowish amorphous solid and subsequently colorless block 
crystals (CH2Cl2hexanes); mp 206208 
o
C; [α]25D +30 (c 0.15, CHCl3); UV (EtOH) 
λmax (log ) 210 (4.01), 224 (4.15), 250 (3.69), and 289 (3.00) nm; IR (dry film) max 




H NMR and 
13
C NMR data, see Table 2.2; ESIMS m/z 441 
(MH
+
); HRESIMS m/z 441.1665 (calcd for C23H24N2O7 + H, 441.1656). HMBC: 
2
J 
H(5) to C(6); H(6) to C(5), C(22); H(9) to C(10); H(10) to C(11); H(15) to C(20); H(17) 
to C(16), C(20); H(18) to C(2); H(19) to C(20); 16-OH to C(16). 
3
J  H(5) to C(3), C(7), 
C(21), C(22); H(6) to C(8); H(9) to C(7), C(11), C(13); H(10) to C(8), C(12); H(15) to 
C(21); H(17) to C(2), C(15), C(21); H(18) to C(7), C(16), C(20); H(19) to C(2), C(17); 
H(21) to C(5), C(6), C(8), C(15), C(17); NCO2Me to NCO2Me; 16-OH to C(2), C(17); 
OCH2O to C(11), C(12).  
 
Crystallographic data of 1 : Colorless block crystals, C23H24N2O7, Mr = 440.44, 
monoclinic, space group P21, a = 9.9492(5) Å, b = 8.2037(4) Å, c = 13.0494(7) Å;  =  
= 90
o
,  = 109.845(3)o, V = 1002(9) Å3, T = 100 K, Z = 2, Dcalcd = 1.460 gcm
3
, crystal 
size 0.06 x 0.15 x 0.58 mm
3
, F(000) = 464. The final R1 value is 0.0504 (wR2 = 0.1220) 
for 2175 reflections [I>2(I)].  
 
Compound 2 : Light yellowish oil and subsequently colorless block crystals (CH2Cl2 
MeOH); mp 180182 
o
C; [α]25D 22 (c 0.13, CHCl3); UV (EtOH) λmax (log ) 209 







C NMR data, see Table 2.3; ESIMS m/z 339 (MH
+
); HRESIMS m/z 
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339.1704 (calcd for C20H22N2O3 + H, 339.1703). HMBC: 
2
J  H(6) to C(5), C(7); H(10) 
to C(11); H(15) to C(20); H(16) to C(2), C(17), CO2Me; H(17) to C(16), C(20); H(18) 
to C(2), C(19); H(19) to C(18), C(20); H(21) to C(7); NH to C(13). 
3
J  H(5) to C(7), 
C(14), C(21); H(6) to C(2), C(8), C(21); H(9) to C(7), C(11); H(10) to C(8), C(12); 
H(11) to C(9), C(13); H(12) to C(8), C(10); H(15) to C(17), C(19); H(16) to C(7), 
C(18); H(17) to C(2), C(15), C(19), C(21), CO2Me; H(18) to C(7), C(16), C(20); H(19) 
to C(17), C(21); H(21) to C(5), C(6), C(8), C(14), C(15), C(17), C(19); CO2Me to 
CO2Me; NH to C(7), C(8).  
 
Crystallographic data of 2 : Colorless block crystals, C20H22N2O3.CH3OH, Mr = 
370.44, orthorhombic, space group P212121, a = 6.7581(2) Å, b = 11.4548(3) Å, c = 
23.3157(6) Å; V = 1804.93(9) Å
3
, T = 100 K, Z = 4, Dcalcd = 1.363 gcm
3
, crystal size 
0.58 x 0.25 x 0.13 mm
3
, F(000) = 792. The final R1 value is 0.0332 (wR2 = 0.993) for 
2163 reflections [I>2(I)].  
 
Compound 3 : Light yellowish oil and subsequently colorless needles 
(CH2Cl2hexanes); mp 268270 
o
C; [α]25D 135 (c 0.11, CHCl3); UV (EtOH) λmax (log 





H NMR and 
13
C NMR data, see Table 2.4; ESIMS m/z 391 (MH
+
); HRESIMS 
m/z 391.2019 (calcd for C24H26N2O3 + H, 391.2016). HMBC: 
2
J  H(6) to C(5), C(7); 
H(10) to C(9), C(11); H(15) to C(14), C(20); H(16) to C(2), CO2Me; H(17) to C(16), 
C(20); H(18) to C(2), C(19); H(19) to C(18), C(20); H(21) to C(7); H(22) to C(3), 
C(23); H(24) to C(14), C(23). 
3
J H(5) to C(7), C(21); H(6) to C(2), C(8), C(21); H(9) to 
C(7), C(11), C(13); H(10) to C(8), C(12); H(11) to C(9), C(13); H(12) to C(8), C(10); 
H(15) to C(17), C(19), C(21), C(24); H(16) to C(7), C(18); H(17) to C(15), C(19), 
C(21), CO2Me; H(18) to C(7), C(16), C(20); H(19) to C(2), C(17), C(21); H(21) to 
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C(3), C(6), C(8), C(17); CO2Me to CO2Me; H(22) to C(14), C(24); H(24) to C(3). 
NOESY: H(5)/H(5), H(6), H(9); H(5)/H(22); H(6)/H(), (6); H(6)/H(6), 
H(17); H(9)/H(5), H(10), H(21); H(10)/H(11); H(11)/H(12); H(12)/H(11); 
H(14)/H(15), H(21), H(24 H(15)/H(), (17); H(15)/H(14), H(15); 
H(16)/H(17), H(18), H(19); H(17)/H(15), H(16), H(17), H(19); 
H(17)/H(6), H(17); H(18)/H(16), H(18); H(18)/H(18), H(19), H(21); 
H(19)/H(18), H(21); H(19)/H(18), H(21); H(19)/H(16), H(18), H(19); 
H(21)/H(14), H(15), H(18), H(19); H(22)/H(5); H(24/H(15), H(24; 
H(24/H(14), H(24. 
 
Crystallographic data of 3 : Colorless needles, C24H26N2O3, CH2Cl2, Mr = 475.39, 
orthorhombic, space group P212121, a = 6.6620(4) Å, b = 9.8110(5) Å, c = 34.4440(18) 
Å; V = 2251.3(2) Å
3
, T = 100 K, Z = 4, Dcalcd = 1.403 gcm
3
, crystal size 0.42 x 0.04 x 
0.02 mm
3
, F(000) = 1000. The final R1 value is 0.0600 (wR2 = 0.1664) for 2773 
reflections [I>2(I)]. The absolute configuration was determined on the basis of Flack 
parameter
161
 of 0.02(12), refined using 1930 Friedel pairs.  
 
Compound 4 : Light yellowish amorphous solid; mp 158
o
C; [α]25D 156 (c 0.72, 
CHCl3); UV (EtOH) λmax (log ) 209 (3.75), 245 (3.63), and 303 (4.24) nm; IR (dry 




H NMR and 
13
C NMR data, see Table 2.5; ESIMS m/z 365 
(MH
+
); HRESIMS m/z 365.1858 (calcd for C22H24N2O3 + H, 365.1860). HMBC: 
2
J 
H(3) to C(14); H(5) to C(6); H(6) to C(5), C(7); H(10) to C(11); H(12) to C(11), C(13); 
H(15) to C(14), C(20); H(16) to C(2), C(17), CO2Me; H(17) to C(16), C(20); H(18) to 
C(2), C(19); H(19) to C(20); H(21) to C(7), C(20); CHO to C(14). 
3
J  H(3) to CHO, 
C(5), C(15), C(21); H(5) to C(21); H(6) to C(2), C(8), C(21); H(9) to C(7), C(11), 
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C(13); H(10) to C(8), C(12); H(11) to C(9), C(13); H(12) to C(8), C(10); H(15) to C(3), 
C(17), C(21), CHO; H(16) to C(7), C(18); H(17) to C(2), C(15), C(19), C(21), CO2Me; 
H(18) to C(7), C(16), C(20); H(19) to C(2), C(15), C(17), C(21); H(21) to C(3), C(5), 
C(6), C(8), C(15), C(17), C(19); CO2Me to CO2Me; CHO to C(3), C(15).  
 
Compound 5 : Light yellowish oil; [α]
25
D 3 (c 0.16, CHCl3); UV (EtOH) λmax (log ) 





H NMR and 
13
C NMR data, see Table 2.6; ESIMS m/z 323 (MH
+
); HRESIMS 
m/z 323.1758 (calcd for C20H22N2O2 + H, 323.1754). HMBC: 
2
J H(3) to C(14); H(5) to 
C(6); H(10) to C(9), C(11); H(11) to C(12); H(12) to C(11); H(14) to C(15); H(15) to 
C(14); H(16) to C(2), C(22); H(17) to C(16), C(20); H(18) to C(2), C(19); H(19) to 
C(18); H(21) to C(7). 
3
J H(3) to C(5), C(15), C(21); H(5) to C(21); H(9) to C(7), C(11), 
C(13); H(10) to C(8), C(12); H(11) to C(9), C(13); H(12) to C(8), C(10); H(15) to C(3), 
C(21); H(16) to C(7); H(17) to C(19), C(21), C(22); H(18) to C(7), C(16), C(20); H(19) 
to C(21); H(21) to C(3), C(5), C(6), C(8); NH to C(7), C(8).  
 
Compound 6 : Light yellowish oil; [α]
25
D 208 (c 0.12, CHCl3); UV (EtOH) λmax (log ) 





H NMR and 
13
C NMR data, see Table 2.7; ESIMS m/z 337 (MH
+
); 
HRESIMS m/z 337.1552 (calcd for C20H20N2O3 + H, 337.1547). HMBC: 
2
J H(3) to 
C(14); H(6) to C(5), C(7); H(10) to C(9), C(11); H(11) to C(10); H(14) to C(3), C(15); 
H(15) to C(20); H(16) to C(2), C(17), C(22); H(17) to C(16), C(20); H(18 to C(19); 
H(19) to C(18), C(20); H(21) to C(7), C(20). 
3
J  H(3) to C(5), C(15), C(21); H(6) to 
C(8), C(21), C(22); H(9) to C(7), C(11), C(13); H(10) to C(8), C(12); H(11) to C(9), 
C(13); H(12) to C(8), C(10); H(14) to C(20); H(15) to C(3), C(17), C(19), C(21); H(16) 
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to C(7); H(17) to C(2), C(19), C(21), C(22); H(18) to C(7), C(16), C(20); H(19) to C(2), 
C(15), C(17), C(21); H(21) to C(5), C(6), C(8), C(19); NH to C(7).  
 
Compound 7 : Light yellowish oil; [α]
25
D  (c 0.11, CHCl3); UV (EtOH) λmax (log ) 







C NMR data, see Table 2.8; ESIMS m/z 409 (MH
+
); HRESIMS m/z 409.1754 
(calcd for C23H24N2O5 + H, 409.1758). HMBC:
 2
J H(6) to C(5), C(22); H(9) to C(10); 
H(10) to C(11); H(11) to C(10), C(12); H(14) to C(15); H(15) to C(14), C(20); H(16) to 
C(17); H(17) to C(20); H(18) to C(2), C(19); H(19) to C(18), C(20); H(21) to C(7), 
C(20). 
3
J  H(3) to C(15), C(21); H(6) to C(8), C(21); H(9) to C(7), C(11), C(13); H(10) 
to C(8), C(12); H(11) to C(9), C(13); H(14) to C(20); H(15) to C(3), C(17), C(19), 
C(21); H(16) to C(7), C(20); H(17) to C(15), C(19), C(21), C(22); H(18) to C(7), C(16), 
C(20); H(19) to C(2), C(15), C(17), C(21); H(21) to C(5), C(6), C(8), C(15), C(17); 
NCO2Me to NCO2Me; 12-OMe to C(12).  
 
Compound 8 : Light yellowish oil and subsequently light orange block crystals 




D 414 (c 0.26, CHCl3); UV (EtOH) λmax (log 
) 210  (4.25), 234 (4.55), 257 (3.96), 308 (3.36), and 376 (3.40) nm; IR (dry film) max 




H NMR and 
13
C NMR data, see Table 2.9; ESIMS m/z 311 
(MH
+
); HRESIMS m/z 311.1756 (calcd for C19H22N2O2 + H, 311.1754). HMBC:
 2
J  
H(5) to C(6); H(6) to C(2), C(5); H(10) to C(11); H(14) to C(15); H(15) to C(14), 
C(20); H(16) to C(17); H(17) to C(16), C(20); H(18) to C(19); H(19) to C(20). 
3
J  H(3) 
to C(15), C(21); H(5) to C(2), C(3), C(21); H(6) to C(7), C(21); H(9) to C(7), C(11), 
C(13); H(10) to C(8), C(12); H(11) to C(9); H(12) to C(8), C(10); H(14) to C(20); 
H(15) to C(3), C(17), C(21); H(16) to C(2), C(19), C(20); H(17) to C(15), C(19), C(21); 
H(18) to C(20); H(19) to C(15), C(21); H(21) to C(3), C(7), C(17). NOE: H(3)/H(3), 
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H(14), H(21); H(3)/H(3), H(14); H(5)/H(3), H(5), H(18; H(6)/H(5); 
H(9)/H(10); H(12)/H(11), H(16); H(14)/H(3,), H(15); H(15)/H(14), H(19); 
H(16)/H(17, H(17)/H(16), H(17), H(19); H(17)/H(16), H(17); H(18/H(15), 
H(19), H(21); H(19)/H(15), H(17), H(18; H(21)/H(18.  
 
Crystallographic data of 8 : Light orange block crystals, C19H22N2O2, Mr = 310.39, 
monoclinic, space group P21, a = 14.2796(4) Å, b = 7.9986(2) Å, c = 15.7780(5) Å;  = 
 = 90o,  = 116.781(2)o, V = 1608(8) Å3, T = 100 K, Z = 4, Dcalcd = 1.281 gcm
3
, crystal 
size 0.10 x 0.22 x 0.72 mm
3
, F(000) = 664. The final R1 value is 0.0409 (wR2 = 0.0916) 
for 3270 reflections [I>2(I)].  
 
Compound 9 : Colorless oil;  [α]
25
D  (c 0.11, CHCl3); UV (EtOH) λmax (log ) 209 




H NMR and 
13
C NMR data, see Table 2.10; ESIMS m/z 309 (MH
+
); HRESIMS m/z 
309.1601 (calcd for C19H20N2O2 + H, 309.1598). HMBC:
 2
J  H(3) to C(14); H(5) to 
C(6); H(6) to C(5), C(7); H(10) to C(9); H(11) to C(12); H(17) to C(16), C(20); H(18) 
to C(19); H(21) to C(2), C(20). 
3
J  H(5) to C(3), C(7), C(21); H(6) to C(2); H(9) to 
C(7), C(11), C(13); H(10) to C(8), C(12); H(11) to C(9), C(13); H(12) to C(8), C(10); 
H(15) to C(19); H(17) to C(15), C(19); H(18) to C(20); H(21) to C(3), C(7), C(15).  
 
Compound 10 : Light yellowish amorphous solid; mp 178180
o
C; [α]25D 17 (c 0.82, 
MeOH); UV (EtOH) λmax (log ) 209 (3.91), 227 (3.99), and 277 (3.43) nm; IR (dry 




H NMR and 
13
C NMR data, see Table 2.11; ESIMS m/z 
311 (MH
+
); HRESIMS m/z 311.1759 (calcd for C19H22N2O2 + H, 311.1754). HMBC:
 2
J  
H(6) to C(5), C(7); H(17) to C(16), C(20); H(18) to C(19); H(21) to C(2), C(20). 
3
J  
H(3) to C(15); H(5) to C(3), C(7), C(21); H(9) to C(11), C(13); H(10) to C(8); H(11) to 
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C(9), C(13); H(12) to C(8), C(10); H(15) to C(17); H(16) to C(20); H(17) to C(15), 
C(21); H(21) to C(3), C(15).  
 





D  (c 0.07, CHCl3); UV (EtOH) λmax (log 




H NMR and 
13
C NMR data, see Table 2.12; ESIMS m/z 295 (MH
+
); HRESIMS m/z 
295.1806 (calcd for C19H22N2O + H, 295.1805). HMBC:
 2
J  H(3) to C(14); H(5) to 
C(6); H(6) to C(5), C(7); H(9) to C(8); H(14) to C(15); H(15) to C(14), C(20); H(16) to 
C(17); H(17) to C(16), C(20); H(18) to C(19); H(19) to C(20); H(21) to C(2), C(20). 
3
J 
H(3) to C(15), C(21); H(5) to C(3), C(7), C(21); H(6) to C(2); H(9) to C(7), C(11), 
C(13); H(10) to C(8), C(12); H(11) to C(9), C(13); H(12) to C(8), C(10); H(15) to C(3), 
C(17), C(19), C(21); H(16) to C(2), C(20); H(17) to C(19), C(21); H(18) to C(20); 
H(19) to C(15), C(17), C(21); H(21) to C(3), C(7), C(15), C(19).  
 
Crystallographic data of 11 : Light orange block crystals, C19H22N2O, Mr = 294.39, 
monoclinic, space group P21, a = 8.6391(10) Å, b = 7.9260(10) Å, c = 11.5438(2) Å;  
=  = 90o,  = 98.4100(10)o, V = 781.945(19) Å3, T = 100 K, Z = 2, Dcalcd =1.250 gcm
3
, 
crystal size 0.15 x 0.16 x 0.34 mm
3
, F(000) = 316. The final R1 value is 0.0373 (wR2 = 
0.1035) for 1705 reflections [I>2(I)].  
 





D 47 (c 0.19, CHCl3); UV (EtOH) λmax (log 




H NMR and 
13
C NMR 
data, see Table 2.13; ESIMS m/z 341 (MH
+
); HRESIMS m/z 341.2220 (calcd for 
C21H28N2O2 + H, 341.2224). HMBC:
 2
J H(6) to C(5), C(7); H(9) to C(8); H(15) to 
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C(14), C(20); H(17) to C(16), C(20); H(18) to C(19); H(21) to C(2), C(20); H(22) to 
C(23); H(23) to C(22). 
3
J  H(3) to C(15), C(21); H(5) to C(3), C(7), C(21); H(6) to C(2); 
H(9) to C(7), C(11), C(13); H(10) to C(8), C(12); H(11) to C(9), C(13); H(12) to C(8), 
C(10); H(15) to C(19); H(16) to C(20), C(22); H(17) to C(15), C(19), C(21); H(18) to 
C(20); H(19) to C(15), C(17); H(21) to C(3), C(7), C(15), C(19); H(22) to C(16).  
 
Crystallographic data of 12 : Colorless block crystals, C21H28N2O2, Mr = 340.45, 
orthorhombic, space group P212121, a = 8.4666(3) Å, b = 12.1895(4) Å, c = 16.9938(6) 
Å; V = 1753.82(10) Å
3
, T = 100 K, Z = 4, Dcalcd =1.289 gcm
3
, crystal size 0.41 x 0.09 x 
0.06 mm
3
, F(000) = 736. The final R1 value is 0.0516 (wR2 = 0.1050) for 1497 
reflections [I>2(I)].  
 
Tetrahydroalstonine (13) : Light yellowish oil; [α]25D −53 (c 0.10, CHCl3); UV 
(EtOH) λmax (log ε) 227 (4.31), 247 (3.77), 282 (3.64), and 291 (3.49) nm; IR (dry film) 




H NMR and 
13
C NMR data, see Table 2.15; ESIMS m/z 353 
(MH
+
, C21H24N2O3 + H).  
 
Leuconoxine (14) : Colorless oil; [α]25D −71 (c 0.08, CHCl3); UV (EtOH) λmax (log ε) 





H NMR and 
13






N(1)-Carbomethoxy-5,22-dioxokopsane (15) : Colorless oil; [α]25D +73 (c 0.12, 
CHCl3); UV (EtOH) λmax (log ε) 210 (4.38), 241 (4.11), and 281 (3.46) nm; IR (dry 




H NMR and 
13
C NMR data, see Tables 2.17 and 






Kopsanone (16) : Colorless oil; [α]25D +126 (c 0.20, CHCl3); UV (EtOH) λmax (log ε) 







C NMR data, see Tables 2.17 and 2.18, respectively; ESIMS, m/z 307 (MH
+
, 
C20H22N2O +H).  
 
Kopsifine (17) : Colorless oil; [α]25D +97 (c 0.04, CHCl3); UV (EtOH) λmax (log ε) 223 





H NMR and 
13





Decarbomethoxykopsifine (18) : Colorless oil; [α]25D +52 (c 0.07, CHCl3); UV (EtOH) 





H NMR and 
13





Paucidactine B (19) : Colorless oil; [α]25D +2 (c 0.11, CHCl3); UV (EtOH) λmax (log ε) 





H NMR and 
13
C NMR data, see Table 2.19; ESIMS m/z 455 (MH
+
, 
C23H22N2O8 + H).  
 
Kopsamine (20) : Colorless crystals (CHCl3Et2O); mp 200201 °C; [α]
25
D 47 (c 
0.21, CHCl3); UV (EtOH) λmax (log ε) 227 (4.36), 248 (3.92), and 286 (2.92) nm; IR 




H NMR and 
13
C NMR data, see Table 2.20; 
ESIMS m/z 457 (MH
+




Kopsamine N-oxide (21) : Light yellowish oil; [α]25D 29 (c 0.36, CHCl3); UV (EtOH) 





H NMR and 
13
C NMR data, see Table 2.20; ESIMS, m/z 473 (MH
+
, 
C24H28N2O8 + H).  
 
Kopsinine (22) : Light yellowish oil; [α]25D 68 (c 0.24, CHCl3); UV (EtOH) λmax (log 







C NMR data, see Tables 2.21 and 2.22, respectively; ESIMS, m/z 339 
(MH
+
, C21H26N2O2 + H).  
 
N(1)-Methoxycarbonyl-12-methoxy-16,17-kopsinine (23) : Light yellowish needles 
(EtOH); mp 150152 °C; [α]25D −60 (c 0.10, CHCl3); UV (EtOH) λmax (log ε) 218 




H NMR and 
13
C 
NMR data, see Tables 2.21 and 2.22, respectively; ESIMS m/z 425 (MH
+
, C24H28N2O5 
+ H).  
 
N(1)-Methoxycarbonyl-12-hydroxy-16,17-kopsinine (24) : Light yellowish oil; []25D 
121 (c 0.04, CHCl3); UV (EtOH) λmax (log ε) 218 (3.98), 248 (3.61), and 290 (3.13) 




H NMR and 
13
C NMR data, see Tables 
2.21 and 2.22, respectively; EIMS m/z 410 (M
+
, C23H26 N2 O5). 
 
Kopsinine N-oxide (25) : Light yellowish oil; [α]25D −56 (c 0.26, CHCl3); UV (EtOH) 





H NMR and 
13
C NMR data, see Tables 2.23 and 2.24, respectively; ESIMS, m/z 355 
(MH
+




N(1)-Methoxycarbonyl-11,12-dimethoxykopsinaline (26) : Colorless prisms (Et2O); 
mp 167168 °C; [α]25D −21 (c 0.09, CHCl3); UV (EtOH) λmax (log ε) 223 (4.44), 251 







C NMR data, see Tables 2.23 and 2.24, respectively; ESIMS, m/z 473 
(MH
+
, C25H32N2O7 + H).  
 
Kopsilongine (27) : Light yellowish oil; [α]25D −21 (c 0.09, CHCl3); UV (EtOH) λmax 





H NMR and 
13
C NMR data, see Tables 2.23 and 2.24, respectively; 
ESIMS m/z 443 (MH
+
, C24H30N2O6 + H). 
 
Pleiocarpine (28) : Colorless prisms (Et2O); mp 149150 °C; [α]
25
D −169 (c 0.08, 
CHCl3); UV (EtOH) λmax (log ε) 204 (4.45), 244 (3.88), 281 (3.99), and 290 (3.51) nm;  




H NMR and 
13
C NMR data, see Tables 2.25 and 
2.26, respectively; ESIMS, m/z 397 (MH
+
, C23H28N2O4 + H).  
 
12-Methoxypleiocarpine (29) : Colorless oil; [α]25D −82 (c 0.15, CHCl3); UV (EtOH) 





H NMR and 
13
C NMR data, see Tables 2.25 and 2.26, respectively; ESIMS m/z 427 
(MH
+
, C24H30N2O5 + H). 
 
Pleiocarpine N-oxide (30) : Light yellowish oil; [α]
25
D  (c 0.27, CHCl3); UV 





H NMR and 
13
C NMR data, see Tables 2.25 and 2.26, respectively; 
ESIMS m/z 413 (MH
+




(+)-Eburnamenine (31) : Colorless oil; []25D 216 (c 0.07, CHCl3); UV (EtOH) λmax 





H NMR and 
13





(+)-Eburnamonine (32) : Light yellowish oil; [α]25D +108 (c 0.24, CHCl3); UV (EtOH) 





H NMR and 
13
C NMR data, see Table 2.27; ESIMS m/z 295 (MH
+
, 
C19H22N2O + H).  
 
()-Eburnamine (33) : Light yellowish oil; [α]25D −77 (c 0.11, CHCl3); UV (EtOH) 





H NMR and 
13





(+)-Isoeburnamine (34) : Light yellowish oil; [α]25D  +93 (c 0.12, CHCl3); UV (EtOH) 





H NMR and 
13
C NMR data, see Table 2.28; ESIMS, m/z 297 (MH
+
, 
C19H25N2O +H).  
 
(+)-19-Oxoeburnamine (35) : Light yellowish oil; [α]25D +83 (c 0.06, CHCl3); UV 
(EtOH) λmax (log ε) 202 (3.81), 229 (4.00), 282 (3.39), and 292 (3.25) nm; IR (dry film) 




H NMR and 
13
C NMR data, see Tables 2.29 and 2.30, 
respectively;  EIMS m/z 310 (M
+




()-19(R)-Hydroxyisoeburnamine (36) : Light yellowish oil; [α]25D 16 (c 0.18, 
CHCl3); UV (EtOH) λmax (log ε) 203 (4.39), 229 (4.53), 282 (3.74), and 292 (3.83) nm; 




H NMR and 
13
C NMR data, see Tables 2.29 and 2.30, 
respectively; EIMS, m/z 312 (M
+
, C19H24N2O2).  
 
(+)-19(R)-Hydroxyeburnamine (37) : Colorless crystals (EtOH); mp 246-248 
o
C; 
[α]25D 111 (c 0.09, CHCl3); UV (EtOH) λmax (log ε) 201 (3.86), 229 (4.02), 283 (3.42), 




H NMR and 
13
C NMR data, see 




(-Norpleiomutine (38) : Light yellowish oil; [α]25D −49 (c 1.21, CHCl3); UV (EtOH) 
λmax (log ε) 208 (4.69), 229 (4.51), 255 (4.09), 287 (3.97), and 293 (3.97) nm; IR (dry 




H NMR and 
13
C NMR data, see Table 2.31; ESIMS m/z 
617 (MH
+
, C40H48N4O2+ H).  
 
(-Demethylnorpleiomutine (39) : Light yellowish oil; [α]25D 87 (c 1.21, CHCl3); 
UV (EtOH) λmax (log ε) 209 (4.48), 230 (4.34), 254 (3.99), 287 (3.89), and 292 (3.84) 




H NMR and 
13
C NMR data, see Table 2.32; 
ESIMS m/z 603 (MH
+
, C39H46N4O2+ H).  
 
(+)-Kopsoffinol (40) : Light yellowish oil; [α]25D +22 (c 0.43, CHCl3); UV (EtOH) λmax 
(log ε) 211 (4.57), 231 (4.49), 254 (4.06), 287 (3.94), and 293 (3.94) nm; IR (dry film) 




H NMR and 
13
C NMR data, see Table 2.33; ESIMS m/z 633 
(MH
+





Alkaloids from K. grandifolia 
 
Grandilodine A (41) : Light yellowish oil and subsequently light yellowish block 
crystals (CH2Cl2MeOH); mp 120122 
o
C; [α]25D 76 (c 1.46, CHCl3); UV (EtOH) λmax 




H NMR and 
13
C NMR data, see Table 2.35; ESIMS m/z 443 (MH
+
); HRESIMS m/z 
443.21880 (calcd for C24H30N2O6 + H, 443.21821). HMBC: 
2
J  H(6) to C(5), C(7); H(9) 
to C(8); H(10) to C(11); H(11) to C(10), C(12); H(15) to C(14); H(17) to C(20); H(18) 
to C(2), C(19); H(19) to C(18), C(20). 
3
J  H(5)  to C(7), C(20); H(6) to C(2), C(21); 
H(9) to C(7), C(11), C(13); H(10) to C(12); H(11) to C(13); H(17) to C(15), CO2Me; 
H(19) to C(15); 21-OMe to C(21); CO2Me to CO2Me; NCO2Me to NCO2Me. NOESY: 
H(6)/H(9); H(6)/H(5); H(9)/H(), (10); H(10)/H(9), H(11); H()/H(), 
H(17); H(16)/H(17), H(19); H(17)/H(), H(16), CO2Me; (18)/H(19), 
NCO2Me; H(19)/H(19), H(16); H(19)/NCO2Me; CO2Me/H(17); NCO2Me/ 
H(18), H(19).    
 
Crystallographic data of 41 : Light yellowish block crystals, C24H30N2O6, Mr = 
442.50, orthorhombic, space group P212121, a = 8.0067(2) Å, b = 11.2455(3) Å, c = 
24.1247(7) Å, V = 2172.17(10) Å
3
, T = 100 K, Z = 4, Dcalcd = 1.353 gcm
3
, crystal size 
0.15 x 0.20 x 0.61 mm
3
, F(000) = 944. The final R1 value is 0.0465 (wR2 = 0.1028) for 
2913 reflections [I>2(I)].  
 
Grandilodine B (42) : White amorphous solid and subsequently colorless block 
crystals (CH2Cl2hexanes); mp 204206 
o
C; [α]25D 66 (c 0.39, CHCl3); UV (EtOH) 





H NMR and 
13





m/z 455.1836 (calcd for C24H26N2O7 + H, 455.1813). HMBC: 
2
J  H(5) to C(6); H(6) to 
C(5), C(7); H(9) to C(10); H(10) to C(11); H(11) to C(10), C(12); H(12) to C(11), 
C(13); H(14) to C(3), C(15); H(15) to C(14), C(20); H(16) to C(2), C(17), CO2Me; 
H(17) to C(16), C(20); H(18) to C(2), C(19); H(19) to C(18), C(20). 
3
J  H(5) to C(3), 
C(7), C(20); H(6) to C(2), C(8); H(9) to C(7), C(11), C(13); H(10) to C(8), C(12); 
H(11) to C(9), C(13); H(12) to C(8), C(10); H(14) to C(20); H(15) to C(3), C(17), 
C(19); H(16) to C(18), C(20); H(17) to C(2), C(15), C(19), CO2Me; H(18) to C(7), 
C(16), C(20); H(19) to C(2), C(15); 21-OMe to C(21); CO2Me to CO2Me; NCO2Me to 
NCO2Me. NOESY: H(6)/H(16); H(9)/H(6), H(10); H(10)/H(9); H(12)/H(11); 
H(16)/H(6), H(17); H(17)/H(16). 
 
Crystallographic data of 42 : Colorless block crystals, C24H26N2O7, Mr = 454.47, 
monoclinic, space group P21, a = 8.6505(2) Å, b = 8.0985(2) Å, c = 15.3926(4) Å,  =  
= 90
o
,  = 90.0057(2)o, V = 1078.34(5) Å3, T = 100 K, Z = 2, Dcalcd = 1.400 gcm
3
, 
crystal size 0.08 x 0.28 x 0.47 mm
3
, F(000) = 480. The final R1 value is 0.0335 (wR2 = 
0.0790) for 2351 reflections [I>2(I)]. 
 
Grandilodine C (43) : Light yellowish oil; [α]
25
D 61 (c 0.55, CHCl3); UV (EtOH) λmax 




H NMR and 
13
C NMR data, see Table 2.37; ESIMS m/z 381 (MH
+
); HRESIMS m/z 
381.14544 (calcd for C21H20N2O5 + H, 381.14450). HMBC: 
2
J  H(5) to C(6); H(6) to 
C(5), C(7); H(10) to C(11); H(11) to C(12); H(12) to C(11); H(14) to C(3), C(15); 
H(15) to C(14), C(20); H(17) to C(16), C(20). 
3
J H(5) to C(3), C(7), C(20); H(6) to 
C(2), C(8); H(9) to C(7), C(11), C(13); H(10) to C(12); H(11) to C(9), C(13); H(14) to 




Lapidilectine A (44) : White amorphous solid; mp 7981ºC; [α]25D 34 (c 2.02, 
CHCl3); UV (EtOH) λmax (log ε) 209 (3.61), 225 (3.47), 253 (3.35), and 289 (2.78) nm; 




H NMR and 
13
C NMR data, see Tables 2.39 and 
2.40, respectively; ESIMS, m/z 441 (MH
+
, C24H28N2O6 + H). 
 
Isolapidilectine A (45) : Light yellowish amorphous solid; mp 8082ºC; [α]25D 89 (c  
1.76, CHCl3); UV (EtOH) λmax (log ε) 211 (2.93), 228 (2.67), 252 (2.46), and 283 (1.91) 




H NMR and 
13
C NMR data, see Tables 2.39 
and 2.40, respectively; ESIMS, m/z 441 (MH
+
, C24H28N2O6 + H).  
 
Lapidilectam (46) : Light yellowish oil; [α]25D 128 (c 0.47, CHCl3); UV (EtOH) λmax 





H NMR and 
13
C NMR data, see Tables 2.39 and 2.40, respectively; ESIMS, 
m/z 455 (MH
+
, C24H26N2O7 + H). 
 
Lapidilectine B (47) : Orange amorphous solid; mp 188190ºC; [α]25D 23 (c 0.45, 
CHCl3); UV (EtOH) λmax (log ε) 209 (2.60), 242 (2.48), and 282 (1.65) nm; IR (dry 




H NMR and 
13
C NMR data, see Table 2.41; ESIMS, m/z 
367 (MH
+
, C21H22N2O4 + H). 
 
3.8 Catalytic Hydrogenation of lapidilectine A (44)  
 
General Procedure : Lapidilectine A (44) (15.3 mg, 0.035 mmol) was dissolved in 
MeOH (5 mL) and then stirred over 10% Pd/C (3 mg) under hydrogen atmosphere at 
room temperature for 1 h. The catalyst was removed by filtration over celite. 
 179 
 
Evaporation of the solvent in vacuo, followed by chromatography of the resulting 
residue (silica gel, CHCl3Me) provided grandilodine A (41) (10.6 mg, 69%). 
 
3.9 Cytotoxicity Assays 
 
Cytotoxicity assays were carried out on KB (human oral epidermoid carcinoma) cell 
line. The cells were maintained in culture flasks in Eagle’s MEM, supplemented with 
10% fetal calf serum and kanamycin (60 g/mL). The KB cells (1.5×105 /mL) were 
seeded in 0.2 ml of culture medium/well in 96-well plates (Corning Glass Works). The 
cells were treated in triplicate with graded concentrations of 5 L test samples and were 
then incubated in a 5% carbon dioxide atmosphere at 37 ºC for 72 h. The MTT assay 
was used to measure the cytotoxicity effect.
162
 The activity was shown as the IC50 value, 
which was the concentration (g/mL) of test compound to give 50% inhibition of cell 
growth.  
 
 
 
 
 
 
 
 
 
 
 
 
